Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
To investigate the effects of carnitine on insulin sensitivity in non-insulin-dependent diabetes, insulin-mediated glucose disposal was measured in nine diabetic patients (age 54 +/- 3 years, BMI 27 +/- 1 kg/mq) during a primed (3 mmol) constant (1.7 mumol/min) intravenous infusion of carnitine. In control experiments, the same patients received saline instead of carnitine. Plasma glucose concentration was maintained constant at the level of 100 mg/dl during both studies while plasma insulin was raised to a plateau of 60 microU/ml. Despite similar insulin levels, whole-body glucose utilization was higher with carnitine (4.05 +/- 0.37 mg/kg/min) than saline infusion (3.52 +/- 0.36). Blood lactate concentrations were similar in the basal state and decreased significantly during carnitine infusion (P less than 0.05-0.005), whereas it remained substantially unchanged during saline infusion. Plasma FFA decreased to a similar level (0.1 mmol/l) in both studies. We conclude that an acute carnitine administration is able to improve insulin sensitivity in NIDDM patients. The lactate data suggest that this effect may at least in part be mediated by carnitine activation of pyruvate dehydrogenase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In these studies, acute carnitine infusion during a hyperinsulinemic-euglycemic clamp was found to increase glucose disposal and whole body carbohydrate oxidation in insulin-resistant subjects (43,44).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [43]
In the citing paper
“A limited number of small scale clinical studies have likewise reported positive outcomes of L-carnitine therapy in humans (43)(44)(45).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [43]
In the citing paper
“Results from a limited number of small scale studies suggest that carnitine supplementation might confer insulin sensitizing actions in glucose intolerant or diabetic humans [16,58,72].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [16]
In the citing paper
“These findings are consistent with three previous reports showing that intravenous infusions of L-carnitine improved insulin sensitivity (measured by hyperinsulinemic euglycemic clamps) in diabetic subjects (Capaldo et al., 1991; Giancaterini et al., 2000; Mingrone et al., 1999).”
From Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility (2012) · cites this paper as Capaldo et al., 1991
Citations
Cites
(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 19,795
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,670
Regulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460
DESBUQUOIS, B., & AURBACH, G. D. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-5-732 · Cited by 1,295
FRITZ, I. B. (1963) · Advances in Lipid Research · doi:10.1016/b978-1-4831-9937-5.50014-4 · Cited by 446
Carnitine in Intermediary Metabolism
Bremer, J. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84498-8 · Cited by 327
New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus
Defronzo, R. A., Ferrannini, E., & Koivisto, V. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90654-x · Cited by 262
Role of carnitine in hepatic ketogenesis.
McGarry, J. D., Robles-Valdes, C., & Foster, D. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4385 · Cited by 260
Carnitine in Intermediary Metabolism
Bremer, J. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67896-2 · Cited by 239
Research works printed but not linked: 1
- Ferrannini, 1988, Interaction of carnitine with insulin-stimulated glucose metabolism in man, Am. J. Physiol., 18, 946
Cited by
Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes
Yeh, G. Y., Eisenberg, D. M., Kaptchuk, T. J., & Phillips, R. S. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1277 · Cited by 861
“Three small controlled short-term metabolic trials examined the acute effects in type 2 diabetes (n 18, n 15, and n 9), showing that intravenous carnitine (or its derivative acetyl-L-carnitine) administration can possibly effect insulin sensitivity and enhance glucose uptake and storage (137,147,148).”
BackgroundMuoio, D. M., Noland, R. C., Kovalik, J.-P., Seiler, S. E., Davies, M. N., DeBalsi, K. L., Ilkayeva, O. R., Stevens, R. D., Kheterpal, I., Zhang, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.005 · Cited by 372
“These findings are consistent with three previous reports showing that intravenous infusions of L-carnitine improved insulin sensitivity (measured by hyperinsulinemic euglycemic clamps) in diabetic subjects (Capaldo et al., 1991; Giancaterini et al., 2000; Mingrone et al., 1999).”
ResultNoland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes
Wilson, R. D., & Islam, M. S. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70739-9 · Cited by 289
“, 1999) by decreasing circulating FFAs and improving insulin sensitivity (Capaldo et al., 1991; Rajasekar et al., 2005).”
BackgroundMethodRole of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa
Jeulin, C. (1996) · Human Reproduction Update · doi:10.1093/humupd/2.2.87 · Cited by 218
Metadata
- Authors
- Capaldo, B., Napoli, R., Di Bonito, P., Albano, G., & Saccà, L.
- Affiliations
- Federico II University Hospital (IT)
- Corresponding author
- Saccà, Luigi
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 1991-12
- Volume
- 14
- Issue
- 3
- Pages
- 191-195
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2060740768
- Cited by
- 75
- References
- 18
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 5 · 2014: 5 · 2013: 1 · 2012: 6
- FWCI
- 0.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Diabetes Research and Clinical Practice (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- L-carnitine, insulin sensitivity, type 2 diabetes, glucose disposal, blood lactate, pyruvate dehydrogenase, free fatty acids
- MeSH terms
- Blood Glucose, Carnitine, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose, Humans, Kinetics, Lactates, Male, Middle Aged, Reference Values, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. https://app.cochat.ai/papers/10.1016/0168-8227(91)90020-e
- The paper
- Capaldo, B., Napoli, R., Di Bonito, P., Albano, G., & Saccà, L. (1991). Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diabetes Research and Clinical Practice. https://doi.org/10.1016/0168-8227(91)90020-e
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.